TRVI – trevi therapeutics, inc. (US:NASDAQ)

News

MarketBeat's Top 5 Rated Small-Cap Stocks [Yahoo! Finance]
Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change [Yahoo! Finance]
Trevi Therapeutics (NASDAQ:TRVI) was given a new $18.00 price target on by analysts at Stifel Nicolaus.
Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer
Trevi Therapeutics (NASDAQ:TRVI) was upgraded by analysts at B. Riley to a "strong-buy" rating.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com